Free Trial
NASDAQ:OCS

Oculis (OCS) Stock Price, News & Analysis

Oculis logo
$18.95 -0.21 (-1.07%)
As of 07/3/2025 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Oculis Stock (NASDAQ:OCS)

Key Stats

Today's Range
$18.94
$19.15
50-Day Range
$17.28
$19.92
52-Week Range
$10.79
$23.08
Volume
8,545 shs
Average Volume
45,517 shs
Market Capitalization
$827.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$35.33
Consensus Rating
Buy

Company Overview

Oculis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
35th Percentile Overall Score

OCS MarketRank™: 

Oculis scored higher than 35% of companies evaluated by MarketBeat, and ranked 715th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Oculis has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Oculis has only been the subject of 2 research reports in the past 90 days.

  • Read more about Oculis' stock forecast and price target.
  • Earnings Growth

    Earnings for Oculis are expected to grow in the coming year, from ($2.09) to ($2.05) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Oculis is -7.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Oculis is -7.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Oculis has a P/B Ratio of 9.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Oculis' valuation and earnings.
  • Percentage of Shares Shorted

    0.07% of the float of Oculis has been sold short.
  • Short Interest Ratio / Days to Cover

    Oculis has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oculis has recently increased by 17.51%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Oculis does not currently pay a dividend.

  • Dividend Growth

    Oculis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.07% of the float of Oculis has been sold short.
  • Short Interest Ratio / Days to Cover

    Oculis has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oculis has recently increased by 17.51%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Oculis this week, compared to 3 articles on an average week.
  • Search Interest

    2 people have searched for OCS on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Oculis insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 22.30% of the stock of Oculis is held by institutions.

  • Read more about Oculis' insider trading history.
Receive OCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oculis and its competitors with MarketBeat's FREE daily newsletter.

OCS Stock News Headlines

OCS - Oculis Holding AG Executives - Morningstar
Oculis Holding AG (OCS) - Yahoo Finance
Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.
Oculis to Participate in Upcoming June Investor Conferences
See More Headlines

OCS Stock Analysis - Frequently Asked Questions

Oculis' stock was trading at $17.00 at the beginning of the year. Since then, OCS shares have increased by 11.5% and is now trading at $18.9550.

Oculis Holding AG (NASDAQ:OCS) announced its quarterly earnings data on Thursday, May, 8th. The company reported ($0.77) earnings per share for the quarter, missing analysts' consensus estimates of ($0.51) by $0.26. The company had revenue of $0.32 million for the quarter, compared to the consensus estimate of $0.22 million. Oculis had a negative net margin of 13,788.70% and a negative trailing twelve-month return on equity of 92.95%.

Shares of OCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oculis investors own include SoFi Technologies (SOFI), Meta Platforms (META), Bitdeer Technologies Group (BTDR), Purpose Bitcoin ETF (BTCC.B), Booz Allen Hamilton (BAH), Broadcom (AVGO) and Atara Biotherapeutics (ATRA).

Company Calendar

Last Earnings
5/08/2025
Today
7/05/2025
Next Earnings (Estimated)
8/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:OCS
Fax
N/A
Employees
2
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$35.33
High Stock Price Target
$41.00
Low Stock Price Target
$32.00
Potential Upside/Downside
+86.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$97.43 million
Net Margins
-13,788.70%
Pretax Margin
-13,815.93%

Debt

Sales & Book Value

Annual Sales
$780 thousand
Price / Cash Flow
N/A
Book Value
$1.91 per share
Price / Book
9.92

Miscellaneous

Free Float
N/A
Market Cap
$827.58 million
Optionable
Not Optionable
Beta
0.29
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:OCS) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners